Adaja E. Baars
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Prevalence, clinical characteristics and treatment response of tremor in chronic inflammatory demyelinating polyneuropathy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 16, 2026
The Diagnostic Accuracy of the Second Revision of the European Academy of Neurology/Peripheral Nerve Society Guideline for Diagnosing Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Journal: European journal of neurology
Published: March 09, 2026
Patient-Reported Outcome Measures for Assessing Health-Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties.
Journal: Journal of the peripheral nervous system : JPNS
Published: February 26, 2025
Long-Term Follow Up in Anti-Contactin-1 Autoimmune Nodopathy.
Journal: Annals of neurology
Published: June 21, 2024
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Journal: The Journal of allergy and clinical immunology
Published: December 23, 2023
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.
Journal: European journal of neurology
Published: December 20, 2023
Author Response: SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
Journal: Neurology
Published: July 03, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Journal: BMC infectious diseases
Published: November 15, 2022
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Journal: Journal of autoimmunity
Published: October 24, 2022
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Journal: Annals of the rheumatic diseases
Published: October 12, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Journal: Annals of the rheumatic diseases
Published: June 09, 2022
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Journal: The Lancet. Rheumatology
Published: May 09, 2022
Last Updated: 09/26/2026